TOI Q4 2024 revenue up 16.9% to $100M; net loss narrows to $13.2M; 2025 guidance revenue $420-450M

Oncology Institute, Inc.

Revenue $100M (+16.9% YoY); net loss $13.2M vs $18.8M; EPS -$0.14 vs -$0.21.
Positive Q4 operating cash flow of $4.2M; SG&A down 12% YoY.
Added six new value-based contracts in H2 2024 covering over 250k lives; dispensary revenue at record.
2025 guidance: revenue $420-$450M, adjusted EBITDA loss $19-$24M, improved free cash flow.
New drug-supplier agreement expected to improve discounts and cost positioning.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001079973-25-000446
form_type: 8-K
ticker: TOI
cik: 0001799191
company_name: Oncology Institute, Inc.
filed_at: 2025-03-24T23:59:59+00:00
discovered_at: 2026-05-14T18:03:04.911563+00:00
generated_at: 2026-05-24T06:48:19.786442+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: neutral
materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001079973-25-000446
json_url: https://secwatch.observer/filing/0001079973-25-000446.json
markdown_url: https://secwatch.observer/filing/0001079973-25-000446.md
text_url: https://secwatch.observer/filing/0001079973-25-000446.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1799191/000107997325000446/0001079973-25-000446-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1799191/000107997325000446/toi_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001079973-25-000446

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.